Table 2.
Crude and age-standardized incidence and mortality rates (ASIR and ASMR) of cervical cancer (C53) in females in the Russian Federation for the years 2007–2018. Calculations performed based on data available by age group. Age standardization performed according the World Health Organization (WHO) Standard Population 2000–2025.
| Year | C53 Crude Incidence/100,000 |
C53 ASIR/100,000 |
C53 Crude Mortality /100,000 |
C53 ASMR/100,000 |
|---|---|---|---|---|
| 2007 | 17.6 (17.3–17.9) | 13.7 (13.4–13.9) | 8.1 (7.9–8.3) | 5.7 (5.6–5.9) |
| 2008 | 18.1 (17.8–18.4) | 14.1 (13.8–14.3) | 7.9 (7.7–8.1) | 5.6 (5.4–5.7) |
| 2009 | 18.8 (18.5–19.1) | 14.7 (14.5–15.0) | 8.1 (7.9–8.3) | 5.7 (5.6–5.9) |
| 2010 | 19.3 (19.0-19.6) | 15.1 (14.8–15.3) | 8.1 (7.9–8.3) | 5.7 (5.5–5.8) |
| 2011 | 19.3 (19.0–19.6) | 15.1 (14.8–15.3) | 8.3 (8.1–8.5) | 5.8 (5.7–6.0) |
| 2012 | 19.6 (19.3–19.9) | 15.4 (15.1–15.6) | 8.3 (8.0–8.5) | 5.8 (5.7–6.0) |
| 2013 | 20.0 (19.7–20.4) | 15.7 (15.4–16.0) | 8.5 (8.3–8.7) | 6.0 (5.8–6.1) |
| 2014 | 20.9 (20.6–21.2) | 16.23 (16.0–16.5) | 8.3 (8.1–8.5) | 5.8 (5.6–5.9) |
| 2015 | 21.3 (21.0–21.6) | 16.6 (16.3–16.9) | 8.4 (8.2–8.7) | 6.0 (5.8–6.1) |
| 2016 | 21.9 (21.6–22.2) | 17.1 (16.8–17.3) | 8.4 (8.2–8.6) | 5.8 (5.7–6.0) |
| 2017 | 22.3 (22.0–22.7) | 17.3 (17.1–17.6) | 8.2 (8.0–8.4) | 5.7 (5.6–5.9) |
| 2018 | 22.6 (22.2–22.9) | 17.4 (17.1–17.7) | 8.1 (7.9–8.3) | 5.6 (5.4–5.7) |
| Mean | 20.1 (19.1–21.2) | 15.7 (14.9–16.5) | 8.2 (8.1–8.3) | 5.8 (5.7–5.8) |